CHE Earnings Date: Feb 24, 2027 (Estimated) — Chemed Corporation
NYSE · Healthcare · Medical Care Facilities
Updated
When is CHE's next earnings date?
Chemed Corporation (CHE) is expected to report Q4 2026 earnings on Wednesday, February 24, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $7.29 on revenue of $705.4M.
How did CHE do in its last earnings report?
In its most recent report on Oct 27, 2026 (Q3 2026), Chemed Corporation posted EPS of $6.75 versus the $6.39 estimate, a beat of 5.6%. Revenue was $690.9M against a $685.0M estimate. The stock's 1-day post-earnings move was +4.8%.
How much does CHE stock move after earnings?
CHE beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.0% (up or down) in the day after earnings.
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
🤖 AI Earnings Analysis
Chemed delivered a solid Q3 beat, with EPS of $6.75 versus $6.39 expected and revenue of $691 million; reported growth figures are inconsistent, limiting confidence in the trend. Its $25.00–$25.75 EPS outlook frames the next test.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | Q3 2026 | 6.39 | 6.75 | +5.63% | $690.9M | ✅ Beat | +4.77% | — | — |
| 2026-07-28 | Q2 2026 | 5.50 | 6.06 | +10.18% | $673.3M | ✅ Beat | +4.20% | +4.27% | +6.11% |
| 2026-04-23 | Q1 2026 | 5.21 | 5.65 | +8.45% | $657.5M | ✅ Beat | +9.96% | +10.97% | +14.72% |
| 2026-02-25 | Q4 2025 | 6.85 | 6.42 | -6.28% | $639.3M | ❌ Miss | -15.00% | -11.92% | -20.29% |
| 2025-10-28 | Q3 2025 | 5.19 | 5.27 | +1.54% | $624.9M | ✅ Beat | +6.06% | +0.03% | +0.69% |
| 2025-07-29 | Q2 2025 | 4.72 | 4.27 | — | $618.8M | ❌ Miss | -10.36% | -7.88% | -1.88% |
| 2025-04-23 | Q1 2025 | 5.55 | 5.63 | +1.44% | $646.9M | ✅ Beat | -6.61% | -0.67% | -4.10% |
| 2025-02-26 | Q4 2024 | 6.78 | 6.83 | +0.74% | $640.0M | ✅ Beat | +7.39% | +9.06% | +12.20% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $709.9M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Segment Vitas | 66.2% | $470.0M | +11.6% | $415.6M | $420.5M | $421.3M | $429.9M |
| Segment Roto Rooter | 33.8% | $239.9M | +5.9% | $248.9M | $231.0M | $226.5M | $231.6M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.